{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:28:57Z","timestamp":1784744937509,"version":"3.55.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173424"],"award-info":[{"award-number":["82173424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Program of Introducing Talents of Discipline to Universities","award":["B20017"],"award-info":[{"award-number":["B20017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09095-6","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:38:30Z","timestamp":1755038310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of Solute Carriers in the Metabolic Reprogramming of Skin Diseases"],"prefix":"10.1007","volume":"68","author":[{"given":"Yihui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"10281","key":"9095_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J (2021) Psoriasis. Lancet 397(10281):1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet"},{"issue":"12","key":"9095_CR2","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S Stander","year":"2021","unstructured":"Stander S (2021) Atopic dermatitis. N Engl J Med 384(12):1136\u20131143. https:\/\/doi.org\/10.1056\/NEJMra2023911","journal-title":"N Engl J Med"},{"key":"9095_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110883","volume":"204110883","author":"SW Lee","year":"2023","unstructured":"Lee SW, Park J, Kim H, Jang J, Choi KM, Baek YS et al (2023) Risk of type 2 diabetes mellitus in adult patients with atopic dermatitis. Diabetes Res Clin Pract 204110883:204110883. https:\/\/doi.org\/10.1016\/j.diabres.2023.110883","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"9095_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.12932\/AP-231022-1484","volume":"41","author":"V Gonzalez-Uribe","year":"2023","unstructured":"Gonzalez-Uribe V, Vidaurri-de la Cruz H, Gomez-Nunez A, Leyva-Calderon JA, Mojica-Gonzalez ZS (2023) Comorbidities & burden of disease in atopic dermatitis. Asian Pac J Allergy Immunol 41(2):97\u2013105. https:\/\/doi.org\/10.12932\/AP-231022-1484","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"6","key":"9095_CR5","first-page":"562","volume":"108","author":"KK Garner","year":"2023","unstructured":"Garner KK, Hoy KDS, Carpenter AM (2023) Psoriasis: recognition and management strategies. Am Fam Physician 108(6):562\u2013573","journal-title":"Am Fam Physician"},{"issue":"8","key":"9095_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41574-025-01107-x","volume":"21","author":"RM Slominski","year":"2025","unstructured":"Slominski RM, Raman C, Jetten AM, Slominski AT (2025) Neuro-immuno-endocrinology of the skin: how environment regulates body homeostasis. Nat Rev Endocrinol 21(8):495\u2013509. https:\/\/doi.org\/10.1038\/s41574-025-01107-x","journal-title":"Nat Rev Endocrinol"},{"issue":"14","key":"9095_CR7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2308374121","volume":"121","author":"RM Slominski","year":"2024","unstructured":"Slominski RM, Chen JY, Raman C, Slominski AT (2024) Photo-neuro-immuno-endocrinology: how the ultraviolet radiation regulates the body, brain, and immune system. Proc Natl Acad Sci U S A 121(14):e2308374121. https:\/\/doi.org\/10.1073\/pnas.2308374121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9095_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109212","volume":"246109212","author":"P Liu","year":"2023","unstructured":"Liu P, Hou G, Kuang Y, Li L, Chen C, Yan B et al (2023) Lipidomic profiling reveals metabolic signatures in psoriatic skin lesions. Clin Immunol 246109212:109212. https:\/\/doi.org\/10.1016\/j.clim.2022.109212","journal-title":"Clin Immunol"},{"issue":"6","key":"9095_CR9","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/all.15569","volume":"78","author":"H Yin","year":"2023","unstructured":"Yin H, Qiu Z, Zhu R, Wang S, Gu C, Yao X et al (2023) Dysregulated lipidome of sebum in patients with atopic dermatitis. Allergy 78(6):1524\u20131537. https:\/\/doi.org\/10.1111\/all.15569","journal-title":"Allergy"},{"key":"9095_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2019.07.016","volume":"59","author":"MR Ruocco","year":"2019","unstructured":"Ruocco MR, Avagliano A, Granato G, Vigliar E, Masone S, Montagnani S et al (2019) Metabolic flexibility in melanoma: a potential therapeutic target. Semin Cancer Biol 59:187\u2013207. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.016","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"9095_CR11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.drudis.2021.03.004","volume":"26","author":"K Rashid","year":"2021","unstructured":"Rashid K, Ahmad A, Liang L, Liu M, Cui Y, Liu T (2021) Solute carriers as potential oncodrivers or suppressors: their key functions in malignant tumor formation. Drug Discov Today 26(7):1689\u20131701. https:\/\/doi.org\/10.1016\/j.drudis.2021.03.004","journal-title":"Drug Discov Today"},{"key":"9095_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101952","volume":"84","author":"K Hushmandi","year":"2024","unstructured":"Hushmandi K, Einollahi B, Saadat SH, Lee EHC, Farani MR, Okina E et al (2024) Amino acid transporters within the solute carrier superfamily: underappreciated proteins and novel opportunities for cancer therapy. Mol Metab 84:101952. https:\/\/doi.org\/10.1016\/j.molmet.2024.101952","journal-title":"Mol Metab"},{"issue":"3","key":"9095_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.356","volume":"11","author":"Z Wu","year":"2021","unstructured":"Wu Z, Xu J, Liang C, Meng Q, Hua J, Wang W et al (2021) Emerging roles of the solute carrier family in pancreatic cancer. Clin Transl Med 11(3):e356. https:\/\/doi.org\/10.1002\/ctm2.356","journal-title":"Clin Transl Med"},{"issue":"1","key":"9095_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1124\/pr.118.015735","volume":"72","author":"T Schumann","year":"2020","unstructured":"Schumann T, Konig J, Henke C, Willmes DM, Bornstein SR, Jordan J et al (2020) Solute carrier transporters as potential targets for the treatment of metabolic disease. Pharmacol Rev 72(1):343\u2013379. https:\/\/doi.org\/10.1124\/pr.118.015735","journal-title":"Pharmacol Rev"},{"issue":"2\u20133","key":"9095_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.mam.2012.07.015","volume":"34","author":"M Rask-Andersen","year":"2013","unstructured":"Rask-Andersen M, Masuram S, Fredriksson R, Schioth HB (2013) Solute carriers as drug targets: current use, clinical trials and prospective. Mol Aspects Med 34(2\u20133):702\u2013710. https:\/\/doi.org\/10.1016\/j.mam.2012.07.015","journal-title":"Mol Aspects Med"},{"issue":"2","key":"9095_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.apsb.2023.09.004","volume":"14","author":"J Le","year":"2024","unstructured":"Le J, Chen Y, Yang W, Chen L, Ye J (2024) Metabolic basis of solute carrier transporters in treatment of type 2 diabetes mellitus. Acta Pharm Sin B 14(2):437\u2013454. https:\/\/doi.org\/10.1016\/j.apsb.2023.09.004","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"9095_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40364-024-00645-2","volume":"12","author":"LL Sun","year":"2024","unstructured":"Sun LL, He HY, Li W, Jin WL, Wei YJ (2024) The solute carrier transporters (SLCs) family in nutrient metabolism and ferroptosis. Biomark Res 12(1):94. https:\/\/doi.org\/10.1186\/s40364-024-00645-2","journal-title":"Biomark Res"},{"issue":"10","key":"9095_CR18","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00125-018-4656-5","volume":"61","author":"C Ghezzi","year":"2018","unstructured":"Ghezzi C, Loo DDF, Wright EM (2018) Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. Diabetologia 61(10):2087\u20132097. https:\/\/doi.org\/10.1007\/s00125-018-4656-5","journal-title":"Diabetologia"},{"issue":"1","key":"9095_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0021-9258(19)44440-2","volume":"248","author":"U Hopfer","year":"1973","unstructured":"Hopfer U, Nelson K, Perrotto J, Isselbacher KJ (1973) Glucose transport in isolated brush border membrane from rat small intestine. J Biol Chem 248(1):25\u201332","journal-title":"J Biol Chem"},{"key":"9095_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00036","author":"RA Busiello","year":"2015","unstructured":"Busiello RA, Savarese S, Lombardi A (2015) Mitochondrial uncoupling proteins and energy metabolism. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2015.00036","journal-title":"Front Physiol"},{"issue":"3","key":"9095_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.tibs.2019.11.001","volume":"45","author":"JJ Ruprecht","year":"2020","unstructured":"Ruprecht JJ, Kunji ERS (2020) The SLC25 mitochondrial carrier family: structure and mechanism. Trends Biochem Sci 45(3):244\u2013258. https:\/\/doi.org\/10.1016\/j.tibs.2019.11.001","journal-title":"Trends Biochem Sci"},{"key":"9095_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2023.01.007","volume":"90","author":"M Singh","year":"2023","unstructured":"Singh M, Afonso J, Sharma D, Gupta R, Kumar V, Rani R et al (2023) Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics? Semin Cancer Biol 901\u201314:901. https:\/\/doi.org\/10.1016\/j.semcancer.2023.01.007","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"9095_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189164","volume":"1879","author":"X Peng","year":"2024","unstructured":"Peng X, He Z, Yuan D, Liu Z, Rong P (2024) Lactic acid: the culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) 1879(5):189164. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189164","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"9095_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1341333","volume":"151341333","author":"K Vagnerova","year":"2024","unstructured":"Vagnerova K, Hudcovic T, Vodicka M, Ergang P, Klusonova P, Petr Hermanova P et al (2024) The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status. Front Pharmacol 151341333:151341333. https:\/\/doi.org\/10.3389\/fphar.2024.1341333","journal-title":"Front Pharmacol"},{"issue":"4","key":"9095_CR25","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1152\/physrev.00028.2018","volume":"99","author":"SF Pedersen","year":"2019","unstructured":"Pedersen SF, Counillon L (2019) The SLC9A-C mammalian Na(+)\/H(+) exchanger family: molecules, mechanisms, and physiology. Physiol Rev 99(4):2015\u20132113. https:\/\/doi.org\/10.1152\/physrev.00028.2018","journal-title":"Physiol Rev"},{"issue":"2\u20133","key":"9095_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.mam.2013.01.001","volume":"34","author":"Y Kanai","year":"2013","unstructured":"Kanai Y, Clemencon B, Simonin A, Leuenberger M, Lochner M, Weisstanner M et al (2013) The SLC1 high-affinity glutamate and neutral amino acid transporter family. Mol Aspects Med 34(2\u20133):108\u2013120. https:\/\/doi.org\/10.1016\/j.mam.2013.01.001","journal-title":"Mol Aspects Med"},{"issue":"2\u20133","key":"9095_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","volume":"34","author":"D Fotiadis","year":"2013","unstructured":"Fotiadis D, Kanai Y, Palacin M (2013) The SLC3 and SLC7 families of amino acid transporters. Mol Aspects Med 34(2\u20133):139\u2013158. https:\/\/doi.org\/10.1016\/j.mam.2012.10.007","journal-title":"Mol Aspects Med"},{"issue":"5","key":"9095_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00424-002-0973-z","volume":"445","author":"F Verrey","year":"2003","unstructured":"Verrey F (2003) System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch 445(5):529\u2013533. https:\/\/doi.org\/10.1007\/s00424-002-0973-z","journal-title":"Pflugers Arch"},{"issue":"1","key":"9095_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/jcmm.14801","volume":"24","author":"BM Rotoli","year":"2020","unstructured":"Rotoli BM, Barilli A, Visigalli R, Ferrari F, Dall\u2019Asta V (2020) y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: implications in the pathophysiology of lysinuric protein intolerance. J Cell Mol Med 24(1):921\u2013929. https:\/\/doi.org\/10.1111\/jcmm.14801","journal-title":"J Cell Mol Med"},{"issue":"1","key":"9095_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47468-1","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Guo Y, Broer A, Dai L, Br\u04e7er S, Yan R (2024) Cryo-EM structure of the human Asc-1 transporter complex. Nat Commun 15(1):3036. https:\/\/doi.org\/10.1038\/s41467-024-47468-1","journal-title":"Nat Commun"},{"key":"9095_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122444","author":"J Lee","year":"2022","unstructured":"Lee J, Roh JL (2022) SLC7A11 as a gateway of metabolic perturbation and ferroptosis vulnerability in cancer. Antioxidants. https:\/\/doi.org\/10.3390\/antiox11122444","journal-title":"Antioxidants"},{"issue":"5","key":"9095_CR32","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"3","key":"9095_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1073\/pnas.1519959113","volume":"113","author":"S Nagamori","year":"2016","unstructured":"Nagamori S, Wiriyasermkul P, Guarch ME, Okuyama H, Nakagomi S, Tadagaki K et al (2016) Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT\/SLC3A1. Proc Natl Acad Sci U S A 113(3):775\u2013780. https:\/\/doi.org\/10.1073\/pnas.1519959113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2\u20133","key":"9095_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","volume":"34","author":"AB Pramod","year":"2013","unstructured":"Pramod AB, Foster J, Carvelli L, Henry LK (2013) SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol Aspects Med 34(2\u20133):197\u2013219. https:\/\/doi.org\/10.1016\/j.mam.2012.07.002","journal-title":"Mol Aspects Med"},{"issue":"2","key":"9095_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350385","volume":"54","author":"L Shao","year":"2024","unstructured":"Shao L, Yang M, Sun T, Xia H, Du D, Li X et al (2024) Role of solute carrier transporters in regulating dendritic cell maturation and function. Eur J Immunol 54(2):e2350385. https:\/\/doi.org\/10.1002\/eji.202350385","journal-title":"Eur J Immunol"},{"issue":"2\u20133","key":"9095_CR36","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.mam.2012.07.012","volume":"34","author":"HB Schioth","year":"2013","unstructured":"Schioth HB, Roshanbin S, Hagglund MG, Fredriksson R (2013) Evolutionary origin of amino acid transporter families SLC32, SLC36 and SLC38 and physiological, pathological and therapeutic aspects. Mol Aspects Med 34(2\u20133):571\u2013585. https:\/\/doi.org\/10.1016\/j.mam.2012.07.012","journal-title":"Mol Aspects Med"},{"issue":"2\u20133","key":"9095_CR37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mam.2013.01.002","volume":"34","author":"N Montalbetti","year":"2013","unstructured":"Montalbetti N, Simonin A, Kovacs G, Hediger MA (2013) Mammalian iron transporters: families SLC11 and SLC40. Mol Aspects Med 34(2\u20133):270\u2013287. https:\/\/doi.org\/10.1016\/j.mam.2013.01.002","journal-title":"Mol Aspects Med"},{"issue":"5","key":"9095_CR38","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00424-003-1074-3","volume":"447","author":"DJ Eide","year":"2004","unstructured":"Eide DJ (2004) The SLC39 family of metal ion transporters. Pflugers Arch 447(5):796\u2013800. https:\/\/doi.org\/10.1007\/s00424-003-1074-3","journal-title":"Pflugers Arch"},{"issue":"2\u20133","key":"9095_CR39","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.mam.2012.05.011","volume":"34","author":"J Jeong","year":"2013","unstructured":"Jeong J, Eide DJ (2013) The SLC39 family of zinc transporters. Mol Aspects Med 34(2\u20133):612\u2013619. https:\/\/doi.org\/10.1016\/j.mam.2012.05.011","journal-title":"Mol Aspects Med"},{"key":"9095_CR40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/B978-0-12-800223-0.00009-8","volume":"73321\u201355","author":"M Schweigel-Rontgen","year":"2014","unstructured":"Schweigel-Rontgen M (2014) The families of zinc (SLC30 and SLC39) and copper (SLC31) transporters. Curr Top Membr 73321\u201355:321. https:\/\/doi.org\/10.1016\/B978-0-12-800223-0.00009-8","journal-title":"Curr Top Membr"},{"issue":"2\u20133","key":"9095_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.mam.2012.07.011","volume":"34","author":"H Kim","year":"2013","unstructured":"Kim H, Wu X, Lee J (2013) SLC31 (CTR) family of copper transporters in health and disease. Mol Aspects Med 34(2\u20133):561\u2013570. https:\/\/doi.org\/10.1016\/j.mam.2012.07.011","journal-title":"Mol Aspects Med"},{"key":"9095_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115163","volume":"203","author":"T Rodrigues","year":"2022","unstructured":"Rodrigues T, Piccirillo S, Magi S, Preziuso A, Dos Santos Ramos V, Serfilippi T et al (2022) Control of Ca(2+) and metabolic homeostasis by the Na(+)\/Ca(2+) exchangers (NCXs) in health and disease. Biochem Pharmacol 203:115163. https:\/\/doi.org\/10.1016\/j.bcp.2022.115163","journal-title":"Biochem Pharmacol"},{"key":"9095_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010598","author":"M Al-Khannaq","year":"2022","unstructured":"Al-Khannaq M, Lytton J (2022) Regulation of K(+)-dependent Na(+)\/Ca(2+)-exchangers (NCKX). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010598","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9095_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.109.002014","volume":"62","author":"CD Klaassen","year":"2010","unstructured":"Klaassen CD, Aleksunes LM (2010) Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62(1):1\u201396. https:\/\/doi.org\/10.1124\/pr.109.002014","journal-title":"Pharmacol Rev"},{"issue":"6","key":"9095_CR45","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/er.2012-1092","volume":"34","author":"AT Slominski","year":"2013","unstructured":"Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC, Rivier J (2013) Key role of CRF in the skin stress response system. Endocr Rev 34(6):827\u2013884. https:\/\/doi.org\/10.1210\/er.2012-1092","journal-title":"Endocr Rev"},{"issue":"5","key":"9095_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/edrv.21.5.0410","volume":"21","author":"A Slominski","year":"2000","unstructured":"Slominski A, Wortsman J (2000) Neuroendocrinology of the skin. Endocr Rev 21(5):457\u2013487. https:\/\/doi.org\/10.1210\/edrv.21.5.0410","journal-title":"Endocr Rev"},{"key":"9095_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115930","author":"X He","year":"2023","unstructured":"He X, Gao X, Xie W (2023) Research progress in skin aging, metabolism, and related products. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242115930","journal-title":"Int J Mol Sci"},{"key":"9095_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1510559","volume":"161510559","author":"D Ruan","year":"2025","unstructured":"Ruan D, Hu T, Yang X, Mo X, Ju Q (2025) Lactate in skin homeostasis: metabolism, skin barrier, and immunomodulation. Front Immunol 161510559:161510559. https:\/\/doi.org\/10.3389\/fimmu.2025.1510559","journal-title":"Front Immunol"},{"key":"9095_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-030-45328-2_11","volume":"1265","author":"F Solano","year":"2020","unstructured":"Solano F (2020) Metabolism and functions of amino acids in the skin. Adv Exp Med Biol 1265:187\u2013199. https:\/\/doi.org\/10.1007\/978-3-030-45328-2_11","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"9095_CR50","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","volume":"84","author":"A Slominski","year":"2004","unstructured":"Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84(4):1155\u20131228. https:\/\/doi.org\/10.1152\/physrev.00044.2003","journal-title":"Physiol Rev"},{"key":"9095_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13091005","author":"M Surbek","year":"2023","unstructured":"Surbek M, Sukseree S, Eckhart L (2023) Iron metabolism of the skin: recycling versus release. Metabolites. https:\/\/doi.org\/10.3390\/metabo13091005","journal-title":"Metabolites"},{"issue":"5","key":"9095_CR52","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1210\/en.2017-03230","volume":"159","author":"AT Slominski","year":"2018","unstructured":"Slominski AT, Zmijewski MA, Plonka PM, Szaflarski JP, Paus R (2018) How UV light touches the brain and endocrine system through skin, and why. Endocrinology 159(5):1992\u20132007. https:\/\/doi.org\/10.1210\/en.2017-03230","journal-title":"Endocrinology"},{"issue":"19","key":"9095_CR53","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"issue":"8","key":"9095_CR54","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DA Vignali","year":"2012","unstructured":"Vignali DA, Kuchroo VK (2012) IL-12 family cytokines: immunological playmakers. Nat Immunol 13(8):722\u2013728. https:\/\/doi.org\/10.1038\/ni.2366","journal-title":"Nat Immunol"},{"issue":"1","key":"9095_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/joim.13235","volume":"290","author":"A Schabitz","year":"2021","unstructured":"Schabitz A, Eyerich K, Garzorz-Stark N (2021) So close, and yet so far away: the dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis. J Intern Med 290(1):27\u201339. https:\/\/doi.org\/10.1111\/joim.13235","journal-title":"J Intern Med"},{"issue":"3","key":"9095_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jdermsci.2008.04.012","volume":"51","author":"J Tao","year":"2008","unstructured":"Tao J, Yang J, Wang L, Li Y, Liu YQ, Dong J et al (2008) Expression of GLUT-1 in psoriasis and the relationship between GLUT-1 upregulation induced by hypoxia and proliferation of keratinocyte growth. J Dermatol Sci 51(3):203\u2013207. https:\/\/doi.org\/10.1016\/j.jdermsci.2008.04.012","journal-title":"J Dermatol Sci"},{"issue":"5","key":"9095_CR57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41591-018-0003-0","volume":"24","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Zi Z, Lee EE, Zhao J, Contreras DC, South AP et al (2018) Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis. Nat Med 24(5):617\u2013627. https:\/\/doi.org\/10.1038\/s41591-018-0003-0","journal-title":"Nat Med"},{"issue":"8","key":"9095_CR58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/ijd.14037","volume":"57","author":"AA Hodeib","year":"2018","unstructured":"Hodeib AA, Neinaa YME, Zakaria SS, Alshenawy HA (2018) Glucose transporter-1 (GLUT-1) expression in psoriasis: correlation with disease severity. Int J Dermatol 57(8):943\u2013951. https:\/\/doi.org\/10.1111\/ijd.14037","journal-title":"Int J Dermatol"},{"issue":"7","key":"9095_CR59","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.immuni.2024.04.022","volume":"57","author":"I Subudhi","year":"2024","unstructured":"Subudhi I, Konieczny P, Prystupa A, Castillo RL, Sze-Tu E, Xing Y et al (2024) Metabolic coordination between skin epithelium and type 17 immunity sustains chronic skin inflammation. Immunity 57(7):1665-1680 e7. https:\/\/doi.org\/10.1016\/j.immuni.2024.04.022","journal-title":"Immunity"},{"key":"9095_CR60","doi-asserted-by":"publisher","DOI":"10.34133\/research.0167","author":"C Chen","year":"2023","unstructured":"Chen C, Yi X, Liu P, Li J, Yan B, Zhang D et al (2023) CD147 facilitates the pathogenesis of psoriasis through glycolysis and H3K9me3 modification in keratinocytes. Research. https:\/\/doi.org\/10.34133\/research.0167","journal-title":"Research"},{"issue":"6","key":"9095_CR61","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF et al (2011) Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186(6):3299\u20133303. https:\/\/doi.org\/10.4049\/jimmunol.1003613","journal-title":"J Immunol"},{"issue":"7","key":"9095_CR62","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jid.2024.01.004","volume":"144","author":"Y Huang","year":"2024","unstructured":"Huang Y, Wang Y, Zhen Y, Liu W, Wang Y, Wang R et al (2024) LPCAT1 facilitates keratinocyte hyperproliferation and skin inflammation in psoriasis by regulating GLUT3. J Invest Dermatol 144(7):1479-1490 e14. https:\/\/doi.org\/10.1016\/j.jid.2024.01.004","journal-title":"J Invest Dermatol"},{"issue":"4","key":"9095_CR63","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","volume":"34","author":"SM Hochrein","year":"2022","unstructured":"Hochrein SM, Wu H, Eckstein M, Arrigoni L, Herman JS, Schumacher F et al (2022) The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab 34(4):516-532.e11. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.015","journal-title":"Cell Metab"},{"issue":"7","key":"9095_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15127","volume":"33","author":"S Nakamizo","year":"2024","unstructured":"Nakamizo S, Doi H, Kabashima K (2024) Metabolic dynamics in psoriatic epidermis: enhanced glucose and lactate uptake, glycolytic pathway and TCA cycle dynamics. Exp Dermatol 33(7):e15127. https:\/\/doi.org\/10.1111\/exd.15127","journal-title":"Exp Dermatol"},{"issue":"1","key":"9095_CR65","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/JCI76012","volume":"125","author":"VA Gerriets","year":"2015","unstructured":"Gerriets VA, Kishton RJ, Nichols AG, Macintyre AN, Inoue M, Ilkayeva O et al (2015) Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest 125(1):194\u2013207. https:\/\/doi.org\/10.1172\/JCI76012","journal-title":"J Clin Invest"},{"key":"9095_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417344","author":"T Kanekura","year":"2023","unstructured":"Kanekura T (2023) CD147\/basigin is involved in the development of malignant tumors and T-cell-mediated immunological disorders via regulation of glycolysis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242417344","journal-title":"Int J Mol Sci"},{"issue":"7","key":"9095_CR67","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s44318-024-00039-y","volume":"43","author":"U Ayyangar","year":"2024","unstructured":"Ayyangar U, Karkhanis A, Tay H, Afandi AFB, Bhattacharjee O, Ks L et al (2024) Metabolic rewiring of macrophages by epidermal-derived lactate promotes sterile inflammation in the murine skin. EMBO J 43(7):1113\u20131134. https:\/\/doi.org\/10.1038\/s44318-024-00039-y","journal-title":"EMBO J"},{"issue":"1","key":"9095_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jaci.2019.09.025","volume":"145","author":"D Cibrian","year":"2020","unstructured":"Cibrian D, Castillo-Gonzalez R, Fernandez-Gallego N, de la Fuente H, Jorge I, Saiz ML et al (2020) Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation. J Allergy Clin Immunol 145(1):199-214 e11. https:\/\/doi.org\/10.1016\/j.jaci.2019.09.025","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"9095_CR69","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.molmed.2020.04.004","volume":"26","author":"D Cibrian","year":"2020","unstructured":"Cibrian D, de la Fuente H, Sanchez-Madrid F (2020) Metabolic pathways that control skin homeostasis and inflammation. Trends Mol Med 26(11):975\u2013986. https:\/\/doi.org\/10.1016\/j.molmed.2020.04.004","journal-title":"Trends Mol Med"},{"issue":"8","key":"9095_CR70","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.7150\/thno.93764","volume":"14","author":"W Liu","year":"2024","unstructured":"Liu W, Jiang J, Li Z, Xiao Y, Zhou S, Wang D et al (2024) Energy competition remodels the metabolic glucose landscape of psoriatic epidermal cells. Theranostics 14(8):3339\u20133357. https:\/\/doi.org\/10.7150\/thno.93764","journal-title":"Theranostics"},{"issue":"13","key":"9095_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202203397","volume":"12","author":"X Jiang","year":"2023","unstructured":"Jiang X, Huang S, Cai W, Wang P, Jiang Z, Wang M et al (2023) Glutamine-based metabolism normalization and oxidative stress alleviation by self-assembled bilirubin\/V9302 nanoparticles for psoriasis treatment. Adv Healthc Mater 12(13):e2203397. https:\/\/doi.org\/10.1002\/adhm.202203397","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"9095_CR72","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","volume":"40","author":"M Nakaya","year":"2014","unstructured":"Nakaya M, Xiao Y, Zhou X, Chang JH, Chang M, Cheng X et al (2014) Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40(5):692\u2013705. https:\/\/doi.org\/10.1016\/j.immuni.2014.04.007","journal-title":"Immunity"},{"issue":"5","key":"9095_CR73","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.immuni.2023.04.001","volume":"56","author":"R Bharadwaj","year":"2023","unstructured":"Bharadwaj R, Lusi CF, Mashayekh S, Nagar A, Subbarao M, Kane GI et al (2023) Methotrexate suppresses psoriatic skin inflammation by inhibiting muropeptide transporter SLC46A2 activity. Immunity 56(5):998-1012 e8. https:\/\/doi.org\/10.1016\/j.immuni.2023.04.001","journal-title":"Immunity"},{"issue":"6","key":"9095_CR74","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00403-009-0933-y","volume":"301","author":"K Thorslund","year":"2009","unstructured":"Thorslund K, El-Nour H, Nordlind K (2009) The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis. Arch Dermatol Res 301(6):449\u2013457. https:\/\/doi.org\/10.1007\/s00403-009-0933-y","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"9095_CR75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00403-012-1303-8","volume":"305","author":"K Thorslund","year":"2013","unstructured":"Thorslund K, Amatya B, Dufva AE, Nordlind K (2013) The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress. Arch Dermatol Res 305(2):99\u2013104. https:\/\/doi.org\/10.1007\/s00403-012-1303-8","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"9095_CR76","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","volume":"61","author":"H Li","year":"2021","unstructured":"Li H, Zhang Z, Zhang H, Guo Y, Yao Z (2021) Update on the pathogenesis and therapy of atopic dermatitis. Clin Rev Allergy Immunol 61(3):324\u2013338. https:\/\/doi.org\/10.1007\/s12016-021-08880-3","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"9095_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8020020","volume":"8","author":"SY Choi","year":"2020","unstructured":"Choi SY, Heo MJ, Lee C, Choi YM, An IS, Bae S et al (2020) 2-deoxy-d-glucose ameliorates animal models of dermatitis. Biomedicines 8(2):20. https:\/\/doi.org\/10.3390\/biomedicines8020020","journal-title":"Biomedicines"},{"key":"9095_CR78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI170706","author":"DM Yu","year":"2023","unstructured":"Yu DM, Zhao J, Lee EE, Kim D, Mahapatra R, Rose EK et al (2023) GLUT3 promotes macrophage signaling and function via RAS-mediated endocytosis in atopic dermatitis and wound healing. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI170706","journal-title":"J Clin Invest"},{"issue":"2","key":"9095_CR79","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/all.14019","volume":"75","author":"K Hayashi","year":"2020","unstructured":"Hayashi K, Kaminuma O, Nishimura T, Saeki M, Matsuoka K, Hiroi T et al (2020) LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation. Allergy 75(2):463\u2013467. https:\/\/doi.org\/10.1111\/all.14019","journal-title":"Allergy"},{"issue":"8","key":"9095_CR80","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/sj.jid.5700824","volume":"127","author":"F Soga","year":"2007","unstructured":"Soga F, Katoh N, Inoue T, Kishimoto S (2007) Serotonin activates human monocytes and prevents apoptosis. J Invest Dermatol 127(8):1947\u20131955. https:\/\/doi.org\/10.1038\/sj.jid.5700824","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9095_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","volume":"123","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI (2019) Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol 123(2):144\u2013151. https:\/\/doi.org\/10.1016\/j.anai.2019.04.020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"9095_CR82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1468-3083.2007.02202.x","volume":"22","author":"SB Lonne-Rahm","year":"2008","unstructured":"Lonne-Rahm SB, Rickberg H, El-Nour H, Marin P, Azmitia EC, Nordlind K (2008) Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol 22(1):11\u201318. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02202.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"9095_CR83","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2340\/00015555-2354","volume":"96","author":"A Rasul","year":"2016","unstructured":"Rasul A, El-Nour H, Lonne-Rahm SB, Fransson O, Johansson C, Johansson B et al (2016) Serotonergic markers in atopic dermatitis. Acta Derm Venereol 96(6):732\u2013736. https:\/\/doi.org\/10.2340\/00015555-2354","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"9095_CR84","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00403-011-1138-8","volume":"303","author":"A Rasul","year":"2011","unstructured":"Rasul A, El-Nour H, Blakely RD, Lonne-Rahm SB, Forsberg J, Johansson B et al (2011) Effect of chronic mild stress on serotonergic markers in the skin and brain of the NC\/Nga atopic-like mouse strain. Arch Dermatol Res 303(9):625\u2013633. https:\/\/doi.org\/10.1007\/s00403-011-1138-8","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"9095_CR85","first-page":"341","volume":"22","author":"M Toyran","year":"2012","unstructured":"Toyran M, Kaymak M, Vezir E, Harmanci K, Kaya A, Ginis T et al (2012) Trace element levels in children with atopic dermatitis. J Investig Allergol Clin Immunol 22(5):341\u2013344","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"9095_CR86","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jdermsci.2007.11.002","volume":"50","author":"H Takahashi","year":"2008","unstructured":"Takahashi H, Nakazawa M, Takahashi K, Aihara M, Minami M, Hirasawa T et al (2008) Effects of zinc deficient diet on development of atopic dermatitis-like eruptions in DS-Nh mice. J Dermatol Sci 50(1):31\u201339. https:\/\/doi.org\/10.1016\/j.jdermsci.2007.11.002","journal-title":"J Dermatol Sci"},{"issue":"2","key":"9095_CR87","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1111\/1346-8138.15190","volume":"47","author":"K Nakajima","year":"2020","unstructured":"Nakajima K, Lee MG, Bin BH, Hara T, Takagishi T, Chae S et al (2020) Possible involvement of zinc transporter ZIP10 in atopic dermatitis. J Dermatol 47(2):e51\u2013e53. https:\/\/doi.org\/10.1111\/1346-8138.15190","journal-title":"J Dermatol"},{"issue":"46","key":"9095_CR88","doi-asserted-by":"publisher","first-page":"12243","DOI":"10.1073\/pnas.1710726114","volume":"114","author":"BH Bin","year":"2017","unstructured":"Bin BH, Bhin J, Takaishi M, Toyoshima KE, Kawamata S, Ito K et al (2017) Requirement of zinc transporter ZIP10 for epidermal development: implication of the ZIP10-p63 axis in epithelial homeostasis. Proc Natl Acad Sci U S A 114(46):12243\u201312248. https:\/\/doi.org\/10.1073\/pnas.1710726114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"9095_CR89","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/1346-8138.14489","volume":"45","author":"E Proksch","year":"2018","unstructured":"Proksch E (2018) pH in nature, humans and skin. J Dermatol 45(9):1044\u20131052. https:\/\/doi.org\/10.1111\/1346-8138.14489","journal-title":"J Dermatol"},{"issue":"1","key":"9095_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5021\/ad.23.078","volume":"36","author":"EH Choi","year":"2024","unstructured":"Choi EH, Kang H (2024) Importance of stratum corneum acidification to restore skin barrier function in eczematous diseases. Ann Dermatol 36(1):1\u20138. https:\/\/doi.org\/10.5021\/ad.23.078","journal-title":"Ann Dermatol"},{"issue":"11","key":"9095_CR91","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL (2020) Systemic lupus erythematosus. Ann Intern Med 172(11):ITC81\u2013ITC96. https:\/\/doi.org\/10.7326\/AITC202006020","journal-title":"Ann Intern Med"},{"issue":"17","key":"9095_CR92","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR (2024) Systemic lupus erythematosus: a review. JAMA 331(17):1480\u20131491. https:\/\/doi.org\/10.1001\/jama.2024.2315","journal-title":"JAMA"},{"issue":"1","key":"9095_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan L, Lu MP, Wang JH, Xu M, Yang SR (2020) Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr 16(1):19\u201330. https:\/\/doi.org\/10.1007\/s12519-019-00229-3","journal-title":"World J Pediatr"},{"issue":"8","key":"9095_CR94","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow MK (2023) Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis 82(8):999\u20131014. https:\/\/doi.org\/10.1136\/ard-2022-223741","journal-title":"Ann Rheum Dis"},{"issue":"274","key":"9095_CR95","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1126\/scitranslmed.aaa0835","volume":"7","author":"Y Yin","year":"2015","unstructured":"Yin Y, Choi SC, Xu Z, Perry DJ, Seay H, Croker BP et al (2015) Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med 7(274):274\u2013318. https:\/\/doi.org\/10.1126\/scitranslmed.aaa0835","journal-title":"Sci Transl Med"},{"issue":"5","key":"9095_CR96","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/art.40785","volume":"71","author":"T Koga","year":"2019","unstructured":"Koga T, Sato T, Furukawa K, Morimoto S, Endo Y, Umeda M et al (2019) Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus. Arthritis Rheumatol 71(5):766\u2013772. https:\/\/doi.org\/10.1002\/art.40785","journal-title":"Arthritis Rheumatol"},{"key":"9095_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110224","volume":"263110224","author":"R Hisada","year":"2024","unstructured":"Hisada R, Kono M (2024) Potential therapies targeting metabolic pathways in systemic lupus erythematosus. Clin Immunol 263110224:110224. https:\/\/doi.org\/10.1016\/j.clim.2024.110224","journal-title":"Clin Immunol"},{"issue":"10","key":"9095_CR98","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/ard-2023-224242","volume":"82","author":"XY Zhao","year":"2023","unstructured":"Zhao XY, Li SS, He YX, Yan LJ, Lv F, Liang QM et al (2023) SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy. Ann Rheum Dis 82(10):1328\u20131340. https:\/\/doi.org\/10.1136\/ard-2023-224242","journal-title":"Ann Rheum Dis"},{"key":"9095_CR99","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002686","author":"H Wang","year":"2022","unstructured":"Wang H, Li T, Sun F, Liu Z, Zhang D, Teng X et al (2022) Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I\/II trial. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2022-002686","journal-title":"RMD Open"},{"issue":"5","key":"9095_CR100","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","volume":"11","author":"A Perl","year":"2015","unstructured":"Perl A, Hanczko R, Lai ZW, Oaks Z, Kelly R, Borsuk R et al (2015) Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin. Metabolomics 11(5):1157\u20131174. https:\/\/doi.org\/10.1007\/s11306-015-0772-0","journal-title":"Metabolomics"},{"key":"9095_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.108987","volume":"237108987","author":"J Tian","year":"2022","unstructured":"Tian J, Li X, Jiang Y, Gao F, Ju B, Chen J et al (2022) SLC7A5 expression is up-regulated in peripheral blood T and B lymphocytes of systemic lupus erythematosus patients, associating with renal damage. Clin Immunol 237108987:108987. https:\/\/doi.org\/10.1016\/j.clim.2022.108987","journal-title":"Clin Immunol"},{"issue":"1","key":"9095_CR102","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1038\/s41467-024-46441-2","volume":"15","author":"N Huang","year":"2024","unstructured":"Huang N, Winans T, Wyman B, Oaks Z, Faludi T, Choudhary G et al (2024) Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation. Nat Commun 15(1):2598. https:\/\/doi.org\/10.1038\/s41467-024-46441-2","journal-title":"Nat Commun"},{"issue":"1","key":"9095_CR103","doi-asserted-by":"publisher","first-page":"e1150","DOI":"10.1002\/ctm2.1150","volume":"13","author":"KR Martin","year":"2023","unstructured":"Martin KR, Day JA, Hansen JA, D\u2019Silva DB, Wong HL, Garnham A et al (2023) CD98 defines a metabolically flexible, proinflammatory subset of low-density neutrophils in systemic lupus erythematosus. Clin Transl Med 13(1):e1150. https:\/\/doi.org\/10.1002\/ctm2.1150","journal-title":"Clin Transl Med"},{"key":"9095_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2024.08.003","volume":"223","author":"Y Wu","year":"2024","unstructured":"Wu Y, Tsai HI, Zhu H, Zhang Y, Liu S, Guo P et al (2024) CX-5461 ameliorates disease in lupus-prone mice by triggering B-cell ferroptosis via p53-SLC7A11-ALOX12 pathway. Free Radic Biol Med 223325\u2013340:223325. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.08.003","journal-title":"Free Radic Biol Med"},{"key":"9095_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103198","volume":"145103198","author":"M Lin","year":"2024","unstructured":"Lin M, Huang L, Huang J, Yu J, Yang X, Yang J (2024) Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice. J Autoimmun 145103198:103198. https:\/\/doi.org\/10.1016\/j.jaut.2024.103198","journal-title":"J Autoimmun"},{"issue":"5","key":"9095_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106774","volume":"26","author":"M Gong","year":"2023","unstructured":"Gong M, Choi SC, Park YP, Zou X, Elshikha AS, Gerriets VA et al (2023) Transcriptional and metabolic programs promote the expansion of follicular helper T cells in lupus-prone mice. iScience 26(5):106774. https:\/\/doi.org\/10.1016\/j.isci.2023.106774","journal-title":"iScience"},{"issue":"8","key":"9095_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112916","volume":"42","author":"H Zhang","year":"2023","unstructured":"Zhang H, Bernaleau L, Delacretaz M, Hasanovic E, Drobek A, Eibel H et al (2023) SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL. Cell Rep 42(8):112916. https:\/\/doi.org\/10.1016\/j.celrep.2023.112916","journal-title":"Cell Rep"},{"issue":"11","key":"9095_CR108","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ng.472","volume":"41","author":"JW Han","year":"2009","unstructured":"Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z et al (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41(11):1234\u20131237. https:\/\/doi.org\/10.1038\/ng.472","journal-title":"Nat Genet"},{"issue":"9","key":"9095_CR109","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ejhg.2012.277","volume":"21","author":"C Wang","year":"2013","unstructured":"Wang C, Ahlford A, Jarvinen TM, Nordmark G, Eloranta ML, Gunnarsson I et al (2013) Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur J Hum Genet 21(9):994\u2013999. https:\/\/doi.org\/10.1038\/ejhg.2012.277","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"9095_CR110","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/annrheumdis-2012-202675","volume":"73","author":"HS Lee","year":"2014","unstructured":"Lee HS, Kim T, Bang SY, Na YJ, Kim I, Kim K et al (2014) Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women. Ann Rheum Dis 73(6):1240\u20131245. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202675","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"9095_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244439","volume":"16","author":"A Katewa","year":"2021","unstructured":"Katewa A, Suto E, Hui J, Heredia J, Liang J, Hackney J et al (2021) The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models. PLoS One 16(1):e0244439. https:\/\/doi.org\/10.1371\/journal.pone.0244439","journal-title":"PLoS One"},{"issue":"7808","key":"9095_CR112","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41586-020-2282-0","volume":"581","author":"LX Heinz","year":"2020","unstructured":"Heinz LX, Lee J, Kapoor U, Kartnig F, Sedlyarov V, Papakostas K et al (2020) TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. Nature 581(7808):316\u2013322. https:\/\/doi.org\/10.1038\/s41586-020-2282-0","journal-title":"Nature"},{"issue":"1","key":"9095_CR113","doi-asserted-by":"publisher","first-page":"6626","DOI":"10.1038\/s41467-023-42070-3","volume":"14","author":"A Boeszoermenyi","year":"2023","unstructured":"Boeszoermenyi A, Bernaleau L, Chen X, Kartnig F, Xie M, Zhang H et al (2023) A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity. Nat Commun 14(1):6626. https:\/\/doi.org\/10.1038\/s41467-023-42070-3","journal-title":"Nat Commun"},{"issue":"3","key":"9095_CR114","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2014.08.011","volume":"41","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T, Shimabukuro-Demoto S, Yoshida-Sugitani R, Furuyama-Tanaka K, Karyu H, Sugiura Y et al (2014) The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. Immunity 41(3):375\u2013388. https:\/\/doi.org\/10.1016\/j.immuni.2014.08.011","journal-title":"Immunity"},{"issue":"7","key":"9095_CR115","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/intimm\/dxab006","volume":"33","author":"T Kobayashi","year":"2021","unstructured":"Kobayashi T, Nguyen-Tien D, Ohshima D, Karyu H, Shimabukuro-Demoto S, Yoshida-Sugitani R et al (2021) Human SLC15A4 is crucial for TLR-mediated type I interferon production and mitochondrial integrity. Int Immunol 33(7):399\u2013406. https:\/\/doi.org\/10.1093\/intimm\/dxab006","journal-title":"Int Immunol"},{"issue":"8","key":"9095_CR116","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1073\/pnas.1222798110","volume":"110","author":"R Baccala","year":"2013","unstructured":"Baccala R, Gonzalez-Quintial R, Blasius AL, Rimann I, Ozato K, Kono DH et al (2013) Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc Natl Acad Sci U S A 110(8):2940\u20132945. https:\/\/doi.org\/10.1073\/pnas.1222798110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9095_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040591","author":"K Fujio","year":"2023","unstructured":"Fujio K (2023) Functional genome analysis for immune cells provides clues for stratification of systemic lupus erythematosus. Biomolecules. https:\/\/doi.org\/10.3390\/biom13040591","journal-title":"Biomolecules"},{"issue":"1","key":"9095_CR118","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-023-44540-0","volume":"15","author":"W Chi","year":"2024","unstructured":"Chi W, Kang N, Sheng L, Liu S, Tao L, Cao X et al (2024) MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation. Nat Commun 15(1):163. https:\/\/doi.org\/10.1038\/s41467-023-44540-0","journal-title":"Nat Commun"},{"key":"9095_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01029","volume":"101029","author":"H Idborg","year":"2019","unstructured":"Idborg H, Zandian A, Ossipova E, Wigren E, Preger C, Mobarrez F et al (2019) Circulating levels of interferon regulatory factor-5 associates with subgroups of systemic lupus erythematosus patients. Front Immunol 101029:101029. https:\/\/doi.org\/10.3389\/fimmu.2019.01029","journal-title":"Front Immunol"},{"issue":"12","key":"9095_CR120","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s00296-015-3298-x","volume":"35","author":"GA Ramirez","year":"2015","unstructured":"Ramirez GA, Lanzani C, Bozzolo EP, Zagato L, Citterio L, Casamassima N et al (2015) Beta-adducin and sodium-calcium exchanger 1 gene variants are associated with systemic lupus erythematosus and lupus nephritis. Rheumatol Int 35(12):1975\u20131983. https:\/\/doi.org\/10.1007\/s00296-015-3298-x","journal-title":"Rheumatol Int"},{"issue":"1","key":"9095_CR121","doi-asserted-by":"publisher","first-page":"214","DOI":"10.55563\/clinexprheumatol\/zte897","volume":"39","author":"G Li","year":"2021","unstructured":"Li G, Liu H, Li Y, Zhang T, Yao W, Guan W et al (2021) Genetic heterogeneity in Chinese children with systemic lupus erythematosus. Clin Exp Rheumatol 39(1):214\u2013222. https:\/\/doi.org\/10.55563\/clinexprheumatol\/zte897","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"9095_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-019-0349-y","volume":"17","author":"I Tirosh","year":"2019","unstructured":"Tirosh I, Spielman S, Barel O, Ram R, Stauber T, Paret G et al (2019) Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies. Pediatr Rheumatol Online J 17(1):52. https:\/\/doi.org\/10.1186\/s12969-019-0349-y","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"9095_CR123","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/art.42021","volume":"74","author":"YF Wang","year":"2022","unstructured":"Wang YF, Wei W, Tangtanatakul P, Zheng L, Lei Y, Lin Z et al (2022) Identification of Shared and <scp>Asian\u2010Specific<\/scp> Loci for Systemic Lupus Erythematosus and Evidence for Roles of Type <scp>III<\/scp> Interferon Signaling and Lysosomal Function in the Disease: A <scp>Multi\u2010Ancestral Genome\u2010Wide<\/scp> Association Study. Arthritis Rheumatol 74(5):840\u2013848. https:\/\/doi.org\/10.1002\/art.42021","journal-title":"Arthritis Rheumatol"},{"key":"9095_CR124","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","volume":"38","author":"ML Frisoli","year":"2020","unstructured":"Frisoli ML, Essien K, Harris JE (2020) Vitiligo: mechanisms of pathogenesis and treatment. Annu Rev Immunol 38:621\u2013648. https:\/\/doi.org\/10.1146\/annurev-immunol-100919-023531","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"9095_CR125","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12864-024-10147-y","volume":"25","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xiang F, Ding Y, Hu W, Wang H, Zhang X et al (2024) Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing. BMC Genomics 25(1):236. https:\/\/doi.org\/10.1186\/s12864-024-10147-y","journal-title":"BMC Genomics"},{"key":"9095_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/nu15214697","author":"Y Wei","year":"2023","unstructured":"Wei Y, Wang T, Nie X, Shi Z, Liu Z, Zeng Y et al (2023) 1,25-Dihydroxyvitamin D3 Provides Benefits in Vitiligo Based on Modulation of CD8+ T Cell Glycolysis and Function. Nutrients. https:\/\/doi.org\/10.3390\/nu15214697","journal-title":"Nutrients"},{"issue":"3","key":"9095_CR127","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/gtmb.2023.0027","volume":"28","author":"X Tang","year":"2024","unstructured":"Tang X, Cheng H, Cheng L, Liang B, Chen M, Zheng X et al (2024) Identification of coding variants in 10q22.1 associated with vitiligo in the Chinese Han population. Genet Test Mol Biomarkers 28(3):123\u2013130. https:\/\/doi.org\/10.1089\/gtmb.2023.0027","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"9095_CR128","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4103\/ijdvl.IJDVL_106_17","volume":"84","author":"L Jiang","year":"2018","unstructured":"Jiang L, Guo Z, Kong Y, Liang J, Wang Y, Wang K (2018) Protective effects of glutamine on human melanocyte oxidative stress model. Indian J Dermatol Venereol Leprol 84(3):269\u2013274. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_106_17","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"9095_CR129","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/exd.14486","volume":"31","author":"MS Ferreira Branquinho","year":"2022","unstructured":"Ferreira Branquinho MS, Silva MBB, Castilho GA, Cavalcante J, Barros SBM, Clara RO et al (2022) Kynurenine inhibits melanogenesis in human melanocyte-keratinocyte co-cultures and in a reconstructed 3D skin model. Exp Dermatol 31(3):427\u2013432. https:\/\/doi.org\/10.1111\/exd.14486","journal-title":"Exp Dermatol"},{"issue":"1","key":"9095_CR130","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jdermsci.2024.06.003","volume":"115","author":"Z Chen","year":"2024","unstructured":"Chen Z, Li Y, Tan X, Nie S, Chen B, Mei X et al (2024) Dysregulated tryptophan metabolism and AhR pathway contributed to CXCL10 upregulation in stable non-segmental vitiligo. J Dermatol Sci 115(1):33\u201341. https:\/\/doi.org\/10.1016\/j.jdermsci.2024.06.003","journal-title":"J Dermatol Sci"},{"issue":"2","key":"9095_CR131","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.humpath.2005.10.007","volume":"37","author":"CA Davies","year":"2006","unstructured":"Davies CA, Jeziorska M, Freemont AJ, Herrick AL (2006) The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis. Hum Pathol 37(2):190\u2013197. https:\/\/doi.org\/10.1016\/j.humpath.2005.10.007","journal-title":"Hum Pathol"},{"issue":"15","key":"9095_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35445","volume":"10","author":"M Masoumi","year":"2024","unstructured":"Masoumi M, Bodaghi AB, Khorramdelazad H, Ebadi E, Houshmandfar S, Saeedi-Boroujeni A et al (2024) Unraveling the immunometabolism puzzle: deciphering systemic sclerosis pathogenesis. Heliyon 10(15):e35445. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35445","journal-title":"Heliyon"},{"issue":"10","key":"9095_CR133","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1093\/rheumatology\/keab022","volume":"60","author":"E Andreucci","year":"2021","unstructured":"Andreucci E, Margheri F, Peppicelli S, Bianchini F, Ruzzolini J, Laurenzana A et al (2021) Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis. Rheumatology 60(10):4508\u20134519. https:\/\/doi.org\/10.1093\/rheumatology\/keab022","journal-title":"Rheumatology"},{"key":"9095_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2018.12.004","volume":"93","author":"H Zhu","year":"2019","unstructured":"Zhu H, Chen W, Liu D, Luo H (2019) The role of metabolism in the pathogenesis of systemic sclerosis. Metabolism 93:44\u201351:44. https:\/\/doi.org\/10.1016\/j.metabol.2018.12.004","journal-title":"Metabolism"},{"issue":"3","key":"9095_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105309","volume":"89","author":"I Sagonas","year":"2022","unstructured":"Sagonas I, Daoussis D (2022) Serotonin and systemic sclerosis. An emerging player in pathogenesis. Joint Bone Spine 89(3):105309. https:\/\/doi.org\/10.1016\/j.jbspin.2021.105309","journal-title":"Joint Bone Spine"},{"issue":"1","key":"9095_CR136","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00281-015-0551-z","volume":"38","author":"O Distler","year":"2016","unstructured":"Distler O, Cozzio A (2016) Systemic sclerosis and localized scleroderma\u2013current concepts and novel targets for therapy. Semin Immunopathol 38(1):87\u201395. https:\/\/doi.org\/10.1007\/s00281-015-0551-z","journal-title":"Semin Immunopathol"},{"issue":"6","key":"9095_CR137","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3899\/jrheum.091156","volume":"37","author":"J Wipff","year":"2010","unstructured":"Wipff J, Bonnet P, Ruiz B, Dieude P, Avouac J, Tiev K et al (2010) Association study of serotonin transporter gene (SLC6A4) in systemic sclerosis in European Caucasian populations. J Rheumatol 37(6):1164\u20131167. https:\/\/doi.org\/10.3899\/jrheum.091156","journal-title":"J Rheumatol"},{"issue":"1","key":"9095_CR138","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-007-9134-7","volume":"28","author":"O Ates","year":"2008","unstructured":"Ates O, Musellim B, Ongen G, Topal-Sarikaya A (2008) NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement. J Clin Immunol 28(1):73\u201377. https:\/\/doi.org\/10.1007\/s10875-007-9134-7","journal-title":"J Clin Immunol"},{"key":"9095_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122582","volume":"344122582","author":"Y Chen","year":"2024","unstructured":"Chen Y, Jian X, Zhu L, Yu P, Yi X, Cao Q et al (2024) PTGS2: a potential immune regulator and therapeutic target for chronic spontaneous urticaria. Life Sci 344122582:122582. https:\/\/doi.org\/10.1016\/j.lfs.2024.122582","journal-title":"Life Sci"},{"issue":"Pt A","key":"9095_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115913","volume":"302","author":"C Sun","year":"2023","unstructured":"Sun C, Liang H, Zhao Y, Li S, Li X, Yuan X et al (2023) Jingfang granules improve glucose metabolism disturbance and inflammation in mice with urticaria by up-regulating LKB1\/AMPK\/SIRT1 axis. J Ethnopharmacol 302(Pt A):115913. https:\/\/doi.org\/10.1016\/j.jep.2022.115913","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"9095_CR141","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00403-019-01969-y","volume":"311","author":"N Zabolinejad","year":"2019","unstructured":"Zabolinejad N, Molkara S, Bakhshodeh B, Ghaffari-Nazari H, Khoshkhui M (2019) The expression of serotonin transporter protein in the skin of patients with chronic spontaneous urticaria and its relation with depression and anxiety. Arch Dermatol Res 311(10):825\u2013831. https:\/\/doi.org\/10.1007\/s00403-019-01969-y","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"9095_CR142","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jaci.2024.01.032","volume":"154","author":"X Jian","year":"2024","unstructured":"Jian X, Hou G, Li L, Diao Z, Wu Y, Wang J et al (2024) Identification of pyruvic and maleic acid as potential markers for disease activity and prognosis in chronic urticaria. J Allergy Clin Immunol 154(2):412\u2013423. https:\/\/doi.org\/10.1016\/j.jaci.2024.01.032","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9095_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44373-x","volume":"15","author":"L Zhu","year":"2024","unstructured":"Zhu L, Jian X, Zhou B, Liu R, Munoz M, Sun W et al (2024) Gut microbiota facilitate chronic spontaneous urticaria. Nat Commun 15(1):112. https:\/\/doi.org\/10.1038\/s41467-023-44373-x","journal-title":"Nat Commun"},{"key":"9095_CR144","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N et al (2022) European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer 170:236\u2013255. https:\/\/doi.org\/10.1016\/j.ejca.2022.03.008","journal-title":"Eur J Cancer"},{"issue":"10400","key":"9095_CR145","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA (2023) Cutaneous melanoma. Lancet 402(10400):485\u2013502. https:\/\/doi.org\/10.1016\/S0140-6736(23)00821-8","journal-title":"Lancet"},{"key":"9095_CR146","doi-asserted-by":"publisher","unstructured":"Slominski RM, Kim TK, Janjetovic Z, Brozyna AA, Podgorska E, Dixon KM et al (2024) Malignant melanoma: an overview, new perspectives, and vitamin D signaling. Cancers (Basel) 16(12).  https:\/\/doi.org\/10.3390\/cancers16122262","DOI":"10.3390\/cancers16122262"},{"issue":"Pt 2","key":"9095_CR147","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.semcancer.2022.07.004","volume":"86","author":"J Pouyssegur","year":"2022","unstructured":"Pouyssegur J, Marchiq I, Parks SK, Durivault J, Zdralevic M, Vucetic M (2022) \u2018Warburg effect\u2019 controls tumor growth, bacterial, viral infections and immunity - genetic deconstruction and therapeutic perspectives. Semin Cancer Biol 86(Pt 2):334\u2013346. https:\/\/doi.org\/10.1016\/j.semcancer.2022.07.004","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"9095_CR148","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12253-017-0363-7","volume":"25","author":"M Dura","year":"2019","unstructured":"Dura M, Nemejcova K, Jaksa R, Bartu M, Kodet O, Ticha I et al (2019) Expression of Glut-1 in malignant melanoma and melanocytic nevi: an immunohistochemical study of 400 cases. Pathol Oncol Res 25(1):361\u2013368. https:\/\/doi.org\/10.1007\/s12253-017-0363-7","journal-title":"Pathol Oncol Res"},{"issue":"11","key":"9095_CR149","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1080\/15384101.2016.1175258","volume":"15","author":"C Pinheiro","year":"2016","unstructured":"Pinheiro C, Miranda-Goncalves V, Longatto-Filho A, Vicente AL, Berardinelli GN, Scapulatempo-Neto C et al (2016) The metabolic microenvironment of melanomas: prognostic value of MCT1 and MCT4. Cell Cycle 15(11):1462\u20131470. https:\/\/doi.org\/10.1080\/15384101.2016.1175258","journal-title":"Cell Cycle"},{"issue":"1","key":"9095_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-27-34","volume":"27","author":"P Parente","year":"2008","unstructured":"Parente P, Coli A, Massi G, Mangoni A, Fabrizi MM, Bigotti G (2008) Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions. J Exp Clin Cancer Res 27(1):34. https:\/\/doi.org\/10.1186\/1756-9966-27-34","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"9095_CR151","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s0190-9622(97)70174-9","volume":"37","author":"SC Baer","year":"1997","unstructured":"Baer SC, Casaubon L, Younes M (1997) Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia. J Am Acad Dermatol 37(4):575\u2013577. https:\/\/doi.org\/10.1016\/s0190-9622(97)70174-9","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"9095_CR152","doi-asserted-by":"publisher","first-page":"e2103534","DOI":"10.1002\/advs.202103534","volume":"9","author":"S Wu","year":"2022","unstructured":"Wu S, Zhang K, Liang Y, Wei Y, An J, Wang Y et al (2022) Nano-enabled tumor systematic energy exhaustion via zinc (II) interference mediated glycolysis inhibition and specific GLUT1 depletion. Adv Sci (Weinh) 9(7):e2103534. https:\/\/doi.org\/10.1002\/advs.202103534","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"9095_CR153","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/CMR.0000000000000626","volume":"29","author":"KN Ruby","year":"2019","unstructured":"Ruby KN, Liu CL, Li Z, Felty CC, Wells WA, Yan S (2019) Diagnostic and prognostic value of glucose transporters in melanocytic lesions. Melanoma Res 29(6):603\u2013611. https:\/\/doi.org\/10.1097\/CMR.0000000000000626","journal-title":"Melanoma Res"},{"key":"9095_CR154","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S245531","volume":"13","author":"C Liu","year":"2020","unstructured":"Liu C, He S, Zhang J, Li S, Chen J, Han C (2020) Silencing TCF4 sensitizes melanoma cells to vemurafenib through inhibiting GLUT3-mediated glycolysis. Onco Targets Ther 134905\u20134915:4905. https:\/\/doi.org\/10.2147\/OTT.S245531","journal-title":"Onco Targets Ther"},{"issue":"1","key":"9095_CR155","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/19336950.2021.1953322","volume":"15","author":"J Xie","year":"2021","unstructured":"Xie J, Zhu Z, Cao Y, Ruan S, Wang M, Shi J (2021) Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma. Channels (Austin) 15(1):483\u2013495. https:\/\/doi.org\/10.1080\/19336950.2021.1953322","journal-title":"Channels (Austin)"},{"issue":"1","key":"9095_CR156","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.canlet.2008.07.034","volume":"273","author":"J Su","year":"2009","unstructured":"Su J, Chen X, Kanekura T (2009) A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett 273(1):140\u2013147. https:\/\/doi.org\/10.1016\/j.canlet.2008.07.034","journal-title":"Cancer Lett"},{"key":"9095_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-11-76","volume":"11","author":"J Ho","year":"2012","unstructured":"Ho J, de Moura MB, Lin Y, Vincent G, Thorne S, Duncan LM et al (2012) Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol Cancer 11:76. https:\/\/doi.org\/10.1186\/1476-4598-11-76","journal-title":"Mol Cancer"},{"issue":"1","key":"9095_CR158","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13105","volume":"225","author":"A Koch","year":"2019","unstructured":"Koch A, Schwab A (2019) Cutaneous pH landscape as a facilitator of melanoma initiation and progression. Acta Physiol (Oxf) 225(1):e13105. https:\/\/doi.org\/10.1111\/apha.13105","journal-title":"Acta Physiol (Oxf)"},{"issue":"7788","key":"9095_CR159","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","volume":"577","author":"A Tasdogan","year":"2020","unstructured":"Tasdogan A, Faubert B, Ramesh V, Ubellacker JM, Shen B, Solmonson A et al (2020) Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature 577(7788):115\u2013120. https:\/\/doi.org\/10.1038\/s41586-019-1847-2","journal-title":"Nature"},{"issue":"8","key":"9095_CR160","first-page":"617","volume":"1","author":"ML Wahl","year":"2002","unstructured":"Wahl ML, Owen JA, Burd R, Herlands RA, Nogami SS, Rodeck U et al (2002) Regulation of intracellular pH in human melanoma: potential therapeutic implications. Mol Cancer Ther 1(8):617\u2013628","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"9095_CR161","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14983","volume":"33","author":"A Koch","year":"2024","unstructured":"Koch A, Hofschroer V, Schwab A (2024) Na(+) \/H(+) exchanger NHE1 is active at cell-cell contacts and facilitates cell dissemination during collective migration of melanoma cells. Exp Dermatol 33(1):e14983. https:\/\/doi.org\/10.1111\/exd.14983","journal-title":"Exp Dermatol"},{"key":"9095_CR162","doi-asserted-by":"publisher","unstructured":"Hofschroer V, Koch A, Ludwig F T, Friedl P, Oberleithner H, Stock C et al (2017) Extracellular protonation modulates cell-cell interaction mechanics and tissue invasion in human melanoma cells. Sci Rep 742369. https:\/\/doi.org\/10.1038\/srep42369","DOI":"10.1038\/srep42369"},{"issue":"5","key":"9095_CR163","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/ijc.28749","volume":"135","author":"Q Wang","year":"2014","unstructured":"Wang Q, Beaumont KA, Otte NJ, Font J, Bailey CG, van Geldermalsen M et al (2014) Targeting glutamine transport to suppress melanoma cell growth. Int J Cancer 135(5):1060\u20131071. https:\/\/doi.org\/10.1002\/ijc.28749","journal-title":"Int J Cancer"},{"issue":"1","key":"9095_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01979-z","volume":"21","author":"C Ai","year":"2023","unstructured":"Ai C, Sun X, Xiao S, Guo L, Shang M, Shi D et al (2023) CAFs targeted ultrasound-responsive nanodroplets loaded V9302 and GLULsiRNA to inhibit melanoma growth via glutamine metabolic reprogramming and tumor microenvironment remodeling. J Nanobiotechnology 21(1):214. https:\/\/doi.org\/10.1186\/s12951-023-01979-z","journal-title":"J Nanobiotechnology"},{"key":"9095_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092151","author":"I Bohme-Schafer","year":"2022","unstructured":"Bohme-Schafer I, Lorentz S, Bosserhoff AK (2022) Role of amino acid transporter SNAT1\/SLC38A1 in human melanoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14092151","journal-title":"Cancers (Basel)"},{"issue":"3","key":"9095_CR166","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/pcmr.12464","volume":"29","author":"N Theodosakis","year":"2016","unstructured":"Theodosakis N, Micevic G, Sharma R, Baras AS, Lazova R, Bosenberg MW et al (2016) Integrative discovery of CD98 as a melanoma biomarker. Pigment Cell Melanoma Res 29(3):385\u2013387. https:\/\/doi.org\/10.1111\/pcmr.12464","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"9095_CR167","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/CMR.0000000000000181","volume":"25","author":"A Shimizu","year":"2015","unstructured":"Shimizu A, Kaira K, Kato M, Yasuda M, Takahashi A, Tominaga H et al (2015) Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma. Melanoma Res 25(5):399\u2013405. https:\/\/doi.org\/10.1097\/CMR.0000000000000181","journal-title":"Melanoma Res"},{"issue":"1","key":"9095_CR168","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbrc.2013.08.020","volume":"439","author":"S Fukumoto","year":"2013","unstructured":"Fukumoto S, Hanazono K, Fu DR, Endo Y, Kadosawa T, Iwano H et al (2013) A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model. Biochem Biophys Res Commun 439(1):103\u2013108. https:\/\/doi.org\/10.1016\/j.bbrc.2013.08.020","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"9095_CR169","doi-asserted-by":"publisher","first-page":"13943","DOI":"10.1038\/s41598-023-41096-3","volume":"13","author":"Z Shi","year":"2023","unstructured":"Shi Z, Kaneda-Nakashima K, Ohgaki R, Xu M, Okanishi H, Endou H et al (2023) Inhibition of cancer-type amino acid transporter LAT1 suppresses B16\u2013F10 melanoma metastasis in mouse models. Sci Rep 13(1):13943. https:\/\/doi.org\/10.1038\/s41598-023-41096-3","journal-title":"Sci Rep"},{"issue":"7","key":"9095_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114484","volume":"43","author":"D Yu","year":"2024","unstructured":"Yu D, Liang J, Widlund HR, Puigserver P (2024) Feedforward cysteine regulation maintains melanoma differentiation state and limits metastatic spread. Cell Rep 43(7):114484. https:\/\/doi.org\/10.1016\/j.celrep.2024.114484","journal-title":"Cell Rep"},{"issue":"11","key":"9095_CR171","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/ijc.33262","volume":"147","author":"M Sato","year":"2020","unstructured":"Sato M, Onuma K, Domon M, Hasegawa S, Suzuki A, Kusumi R et al (2020) Loss of the cystine\/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice. Int J Cancer 147(11):3224\u20133235. https:\/\/doi.org\/10.1002\/ijc.33262","journal-title":"Int J Cancer"},{"issue":"9","key":"9095_CR172","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11626-023-00819-6","volume":"59","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu T, Liu Y, Liu Y, Bai S, Chen Q et al (2023) Establishment of SLC7A11-knockout mouse and its preliminary investigation in melanoma. In Vitro Cell Dev Biol Anim 59(9):729\u2013737. https:\/\/doi.org\/10.1007\/s11626-023-00819-6","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"7","key":"9095_CR173","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.ymthe.2021.03.013","volume":"29","author":"N Liu","year":"2021","unstructured":"Liu N, Zhang J, Yin M, Liu H, Zhang X, Li J et al (2021) Inhibition of xCT suppresses the efficacy of anti-PD-1\/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization. Mol Ther 29(7):2321\u20132334. https:\/\/doi.org\/10.1016\/j.ymthe.2021.03.013","journal-title":"Mol Ther"},{"issue":"12","key":"9095_CR174","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L et al (2019) Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov 9(12):1673\u20131685. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0338","journal-title":"Cancer Discov"},{"issue":"7755","key":"9095_CR175","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gijon M, Kennedy PD, Johnson JK et al (2019) CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569(7755):270\u2013274. https:\/\/doi.org\/10.1038\/s41586-019-1170-y","journal-title":"Nature"},{"key":"9095_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.930041","volume":"13930041","author":"H Lv","year":"2022","unstructured":"Lv H, Liu X, Zeng X, Liu Y, Zhang C, Zhang Q et al (2022) Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in melanoma. Front Pharmacol 13930041:13930041. https:\/\/doi.org\/10.3389\/fphar.2022.930041","journal-title":"Front Pharmacol"},{"key":"9095_CR177","doi-asserted-by":"publisher","unstructured":"Liu Z, Cheng Q, Ma X, Song M (2022) Suppressing effect of Na(+)\/Ca(2+) exchanger (NCX) inhibitors on the growth of melanoma cells. Int J Mol Sci 23(2).  https:\/\/doi.org\/10.3390\/ijms23020901","DOI":"10.3390\/ijms23020901"},{"key":"9095_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.842496","volume":"12842496","author":"RM Slominski","year":"2022","unstructured":"Slominski RM, Sarna T, Plonka PM, Raman C, Brozyna AA, Slominski AT (2022) Melanoma, melanin, and melanogenesis: the yin and yang relationship. Front Oncol 12842496:12842496. https:\/\/doi.org\/10.3389\/fonc.2022.842496","journal-title":"Front Oncol"},{"key":"9095_CR179","doi-asserted-by":"publisher","unstructured":"Slominski A, Kim T K, Brozyna A A, Janjetovic Z, Brooks D L, Schwab L P, et al. (2014) The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1alpha expression and HIF-dependent attendant pathways. Arch Biochem Biophys 56379\u201393. https:\/\/doi.org\/10.1016\/j.abb.2014.06.030","DOI":"10.1016\/j.abb.2014.06.030"},{"issue":"2","key":"9095_CR180","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12626","volume":"68","author":"AT Slominski","year":"2020","unstructured":"Slominski AT, Kim TK, Kleszczynski K, Semak I, Janjetovic Z, Sweatman T et al (2020) Characterization of serotonin and N-acetylserotonin systems in the human epidermis and skin cells. J Pineal Res 68(2):e12626. https:\/\/doi.org\/10.1111\/jpi.12626","journal-title":"J Pineal Res"},{"issue":"6","key":"9095_CR181","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.jid.2024.11.012","volume":"145","author":"AT Slominski","year":"2025","unstructured":"Slominski AT, Kim TK, Janjetovic Z, Slominski RM, Ganguli-Indra G, Athar M et al (2025) Melatonin and the skin: current progress and perspectives for human health. J Invest Dermatol 145(6):1345-1360 e2. https:\/\/doi.org\/10.1016\/j.jid.2024.11.012","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9095_CR182","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1096\/fj.04-2079rev","volume":"19","author":"A Slominski","year":"2005","unstructured":"Slominski A, Wortsman J, Tobin DJ (2005) The cutaneous serotoninergic\/melatoninergic system: securing a place under the sun. FASEB J 19(2):176\u2013194. https:\/\/doi.org\/10.1096\/fj.04-2079rev","journal-title":"FASEB J"},{"key":"9095_CR183","doi-asserted-by":"publisher","DOI":"10.3390\/cells13191615","author":"AM Mousa","year":"2024","unstructured":"Mousa AM, Enk AH, Hassel JC, Reschke R (2024) Immune checkpoints and cellular landscape of the tumor microenvironment in non-melanoma skin cancer (NMSC). Cells. https:\/\/doi.org\/10.3390\/cells13191615","journal-title":"Cells"},{"issue":"6","key":"9095_CR184","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/1066896915589968","volume":"23","author":"AG Abdou","year":"2015","unstructured":"Abdou AG, Eldien MM, Elsakka D (2015) GLUT-1 expression in cutaneous basal and squamous cell carcinomas. Int J Surg Pathol 23(6):447\u2013453. https:\/\/doi.org\/10.1177\/1066896915589968","journal-title":"Int J Surg Pathol"},{"issue":"3","key":"9095_CR185","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/PAI.0b013e3181f7b2f0","volume":"19","author":"D Cabibi","year":"2011","unstructured":"Cabibi D, Aragona F, Guarnotta C, Rodolico V, Zerilli M, Belmonte B et al (2011) Glut-1 expression and in situ CD1a\/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients. Appl Immunohistochem Mol Morphol 19(3):239\u2013245. https:\/\/doi.org\/10.1097\/PAI.0b013e3181f7b2f0","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"9095_CR186","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s41467-018-03914-5","volume":"9","author":"L Zhou","year":"2018","unstructured":"Zhou L, Wang Y, Zhou M, Zhang Y, Wang P, Li X et al (2018) HOXA9 inhibits HIF-1alpha-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. Nat Commun 9(1):1480. https:\/\/doi.org\/10.1038\/s41467-018-03914-5","journal-title":"Nat Commun"},{"issue":"6","key":"9095_CR187","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1600-0560.2012.01912.x","volume":"39","author":"L Sweeny","year":"2012","unstructured":"Sweeny L, Dean NR, Frederick JW, Magnuson JS, Carroll WR, Desmond RA et al (2012) CD147 expression in advanced cutaneous squamous cell carcinoma. J Cutan Pathol 39(6):603\u2013609. https:\/\/doi.org\/10.1111\/j.1600-0560.2012.01912.x","journal-title":"J Cutan Pathol"},{"issue":"10","key":"9095_CR188","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.prp.2014.05.001","volume":"210","author":"K Hirano","year":"2014","unstructured":"Hirano K, Uno K, Kuwabara H, Kojima K, Ohno S, Sakurai H et al (2014) Expression of l-type amino acid transporter 1 in various skin lesions. Pathol Res Pract 210(10):634\u2013639. https:\/\/doi.org\/10.1016\/j.prp.2014.05.001","journal-title":"Pathol Res Pract"},{"issue":"5","key":"9095_CR189","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/ced.15038","volume":"47","author":"S Prosen","year":"2022","unstructured":"Prosen S, Tina E, Sneckenborg AH, Loinder C, Seifert O, Lindberg M et al (2022) Increased expression of LAT1 in basal cell carcinoma: implications for tumour cell survival. Clin Exp Dermatol 47(5):910\u2013917. https:\/\/doi.org\/10.1111\/ced.15038","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"9095_CR190","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/bjd.16905","volume":"180","author":"E Tina","year":"2019","unstructured":"Tina E, Prosen S, Lennholm S, Gasparyan G, Lindberg M, Gothlin Eremo A (2019) Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma. Br J Dermatol 180(1):130\u2013140. https:\/\/doi.org\/10.1111\/bjd.16905","journal-title":"Br J Dermatol"},{"issue":"2","key":"9095_CR191","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3892\/ol.2017.6452","volume":"14","author":"S Prosen","year":"2017","unstructured":"Prosen S, Eremo AG, Tsegai AD, Lindberg M, Tina E (2017) Decreased expression of the mitochondrial solute carrier SLC25A43 in basal cell carcinoma compared with healthy skin. Oncol Lett 14(2):2218\u20132222. https:\/\/doi.org\/10.3892\/ol.2017.6452","journal-title":"Oncol Lett"},{"issue":"4","key":"9095_CR192","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195151","volume":"13","author":"M Nagane","year":"2018","unstructured":"Nagane M, Kanai E, Shibata Y, Shimizu T, Yoshioka C, Maruo T et al (2018) Sulfasalazine, an inhibitor of the cystine-glutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma. PLoS One 13(4):e0195151. https:\/\/doi.org\/10.1371\/journal.pone.0195151","journal-title":"PLoS One"},{"issue":"6","key":"9095_CR193","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1365-2559.2006.02407.x","volume":"48","author":"DE Burstein","year":"2006","unstructured":"Burstein DE, Nagi C, Kohtz DS, Lumerman H, Wang BY (2006) Immunohistochemical detection of GLUT1, p63 and phosphorylated histone H1 in head and neck squamous intraepithelial neoplasia: evidence for aberrations in hypoxia-related, cell cycle- and stem-cell-regulatory pathways. Histopathology 48(6):708\u2013716. https:\/\/doi.org\/10.1111\/j.1365-2559.2006.02407.x","journal-title":"Histopathology"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09095-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09095-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09095-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:30:53Z","timestamp":1757453453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09095-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9095"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09095-6","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"3 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}